Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy.

Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy.

<h4>Introduction</h4>Pancreatic ductal adenocarcinoma is associated to dismal prognosis despite the use of palliative chemotherapy, partly due to the lack of knowledge of biological processes underlying disease progression. Exosomes have been identified as biomarkers sources in different...

Full description

Bibliographic Details
Main Authors: Riccardo Giampieri, Francesco Piva, Giulia Occhipinti, Alessandro Bittoni, Alessandra Righetti, Silvia Pagliaretta, Alberto Murrone, Francesca Bianchi, Consuelo Amantini, Matteo Giulietti, Giulia Ricci, Giovanni Principato, Giorgio Santoni, Rossana Berardi, Stefano Cascinu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0215990

Internet

https://doi.org/10.1371/journal.pone.0215990

Similar Items